| 영문 | tuberculosis | 한글 | 결핵 |
|---|---|---|---|
| 설명 | 결핵균에 의한 사람이나 동물의 감염으로서, 결절형성과 조직의 치즈괴사(caseation necrosis)가 특징이다. 주된 원인균은 Mycobacterium tuberculosis, M. bovis, M. avium, M. kansasii와 기타 분류되지 않은 비전형의 미코박테륨도 원인균이 된다. 전형적인 질병과는 임상적으로도 형태학적으로도 구별할 수 없는 비정형감염은, 사람에서 사람으로 직접 감염을 일으키는 것으로 생각되지 않는다. 결핵증은 그 증상의 발현에 있어 대단히 다양하며 만성화되기 쉽다. 모든 장기에 감염이 일어나지만, 사람에 있어서는 주로 폐가 침범되며, 그곳으로부터 혈관과 림프관을 통해 다른 장기에 감염된다. 증상은 오후의 미열과 수면중의 가벼운 식은 땀 등과 함께 침범된 장기의 기능 저하에 따른 증상이 동반된다. 치료는 항결핵제의 장기간, 집중적인 투여이며 필요에 따라서는 수술을 하기도 한다. |
||
| 영문 | Mycobacterium tuberculosis | 한글 | 결핵균 |
|---|---|---|---|
| 설명 | 미코박테륨속의 사람 결핵을 일으키는 균이다. 1882년 코흐(Koch)에 의해 발견되었다. 그램양성 산소성 막대균이며 0.3~0.6×2~4μm, 무아포, 항산성이다. 항산, 항알칼리, 항알코올, 소독제에 저항한다. 저항력과 번식력이 강하여 전염성이 높으나 건조, 열, 햇빛에는 약하다. 세포벽에는 다량의 지방질이 포함되어 있다. 니아신검사는 사람형 결핵균만 양성이며 이것은 감별에 도움이 된다. 감염은 비말감염이고 폐결핵이 많지만 혈행 속에 들어가면 모든 장기에 결핵을 일으킨다. 특유한 결핵결절을 형성한다. 결핵의 진단에는 트베르쿨린 반응이 사용되며 예방에는 비씨지(BCG) 접종이 실시된다. 면역은 세포성 면역이며 큰포식세포의 활성화로 인해 균의 증식이 억제된다. |
||
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
|---|---|
| MEDAC Syndrome | Multiple-Endocrine Deficiency Autoimmune-Candidiasis |
| AEP | acute edematous pancreatitis; artificial endocrine pancreas; auditory evoked potential; average evok... |
| AES | acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society... |
| EC | effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme... |
| M. tuberculosis | Mycobacterium tuberculosis |
|---|---|
| EO | Endocrine Ophthalmopathy |
| EACs | Endocrine active compounds |
| EDC | Endocrine disrupting chemicals |
| EPT | Endocrine pancreatic tumors |
| tuberculosis, endocrine | Tuberculous infection of the endocrine glands. (12 Dec 1998) |
|---|
| bone diseases, endocrine | Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands. (12 Dec 1998) |
|---|---|
| multiple endocrine adenomatosis | The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance. Synonym: multiple endocrine adenomatosis. (05 Mar 2000) |
| multiple endocrine deficiency syndrome | <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis. Synonym: multiple glandular deficiency syndrome. (05 Mar 2000) |
| multiple endocrine neoplasia | (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour. (type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor. Incidence: approximately 3 in 100,000 people in the general population. Origin: Gr. Plassein = to form (27 Sep 1997) |
| multiple endocrine neoplasia 1 | <radiology> Multiple endrocrine neoplasia syndrome three P's. Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%). Synonym: Wermer syndrome (12 Dec 1998) |
| multiple endocrine neoplasia 2 | <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia Synonym: Sipple syndrome (12 Dec 1998) |
| multiple endocrine neoplasia 3 | <radiology> Multiple endocrine neoplasia syndrome (type 2B, type 3), medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus (Cf: Marfan syndrome), mucosal neuromas, neurofibromas, ganglioneuromatosis coli More info: MEN syndrome 2B Synonym: Schimke, marfanoid syndrome (12 Dec 1998) |
| multiple endocrine neoplasia type 1 | A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients. (12 Dec 1998) |
| multiple endocrine neoplasia type 2 | <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor. Incidence: approximately 3 in 100,000 people in the general population. (27 Sep 1997) |
| multiple endocrine neoplasia type 2a | A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands. (12 Dec 1998) |
| multiple endocrine neoplasia type 2b | A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas. (12 Dec 1998) |
| neoplastic endocrine-like syndromes | Endocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues. They are often the first indication of a previously undetected neoplasm. (12 Dec 1998) |
| diagnostic techniques, endocrine | Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes. (12 Dec 1998) |
| endocrine | Pertaining to internal secretions, hormonal. Compare: exocrine. Origin: Gr. Krinein = to separate (18 Nov 1997) |
| endocrine cells of gut | Cells found throughout the lining of the gastrointestinal tract that contain regulatory peptide hormones and/or biogenic amines. The substances are located in secretory granules and act in an endocrine or paracrine manner. Some of these substances are also found in neurons in the gut. There are at least 15 different types of endocrine cells of the gut. Some take up amine precursors and have been called apud cells. However, most endocrine cells of the gut apparently have endodermal rather than neuroectodermal origin, so the relationship with apud cells is not clear. (12 Dec 1998) |
Synonyms : Endocrine Tuberculoses, Endocrine Tuberculosis, Tuberculoses, Endocrine
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|